Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease.
about
Neuropeptides in depression: role of VGFBiomarkers of Alzheimer's diseaseRapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host responseRecent cerebrospinal fluid biomarker studies of Alzheimer's disease.Identification of a novel biomarker candidate, a 4.8-kDa peptide fragment from a neurosecretory protein VGF precursor, by proteomic analysis of cerebrospinal fluid from children with acute encephalopathy using SELDI-TOF-MSPerformance of PLS regression coefficients in selecting variables for each response of a multivariate PLS for omics-type dataThe expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment.Neuroendocrine Role for VGF.Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis.Peptide profiling of cerebrospinal fluid by mass spectrometry.Large-scale identification of endogenous secretory peptides using electron transfer dissociation mass spectrometryBiomarkers of basic activities of daily living in Alzheimer's disease.Mass spectrometry-based neurochemical analysis: perspectives for primate research.NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders.Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Use of proteomic methods in the analysis of human body fluids in Alzheimer research.Cerebrospinal fluid analysis in Alzheimer's disease: technical issues and future developments.Proteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration.A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression.Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment.Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3.A novel approach for characterizing variations in serum peptides in rheumatic heart disease.Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases.Evolving Relevance of Neuroproteomics in Alzheimer's Disease.Biomarkers for Alzheimer’s disease
P2860
Q24647788-0F732410-1B88-4490-B975-37FBBD159BDCQ24650667-ED7ABAA7-FDA2-40E0-B60C-BBB083D212C8Q28475384-2499ECB3-AD69-46AB-B77E-6BB07A2F2B86Q33766323-962C4126-E933-4505-B9FD-A73DA996D282Q33992022-27285DC2-76B4-49BF-A4AD-9C05581C5A2CQ34019758-1335ED88-4560-4BE1-B0E7-DC66B4D22A92Q34661044-80493E37-9E8C-4F6C-A167-C18B83AF6F51Q35037796-1BBFD16F-48C2-4941-8FD0-05BCFC2E5F4BQ35641886-573914A7-E3F5-4554-8229-0C87C150674EQ36505671-65B09B7C-6975-478C-AD1E-119AB79EC126Q36666362-581830CB-139C-488F-8A82-B91876E4A865Q36818214-C89E5587-C7BC-4DBF-A3CF-09DBCCCC9802Q37304110-09C0493B-C91F-479B-B0CA-8BD20B71BF4FQ37399106-A5240071-2719-434F-AA5F-ADEB4D0A5B0BQ37881948-6D00EA8F-A5D2-4B53-A0B1-107B155A1FF0Q38060574-63EA0F50-BCF9-4A38-9389-1B3188C51943Q38210117-1649C1AE-A5FA-4B03-83D5-F999AA05B8DCQ38403840-10A85CA7-6B13-49EA-83DE-900523A87D6EQ38644393-1DFB9264-9942-4AC9-B2E4-E84822031A46Q38992067-876EA24B-7574-49F2-AE14-D914E99B7EDBQ39516883-F15841F8-14A2-46F6-B0C1-665411BD115DQ40045948-C88FD22D-2A8F-4C0F-A4D1-1A7CFF8C2ECEQ46628274-15915BFD-CB2B-4EFB-83BA-5B052FD729BEQ50999408-E07330B7-CA34-4AC1-AB90-B3900221A675Q58186173-C1449B46-14D7-47E9-ACCF-0A916AB2E2DA
P2860
Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Identification of novel biomar ...... fluid in Alzheimer's disease.
@ast
Identification of novel biomar ...... fluid in Alzheimer's disease.
@en
type
label
Identification of novel biomar ...... fluid in Alzheimer's disease.
@ast
Identification of novel biomar ...... fluid in Alzheimer's disease.
@en
prefLabel
Identification of novel biomar ...... fluid in Alzheimer's disease.
@ast
Identification of novel biomar ...... fluid in Alzheimer's disease.
@en
P2093
P921
P1476
Identification of novel biomar ...... fluid in Alzheimer's disease.
@en
P2093
Andreas Dessauer
Hans-Dieter Zucht
Hartmut Selle
Hayrettin Tumani
Jens Lamerz
Johann Karl
Jukka Louhija
Katharina Buerger
Klaus Hager
Lars Lannfelt
P304
P356
10.2174/138620705774962391
P577
2005-12-01T00:00:00Z